Mona Boules Selected Research

neurotensin 69L

6/2012	NTS1 and NTS2 mediate analgesia following neurotensin analog treatment in a mouse model for visceral pain.
10/2011	The role of NTS2 in the development of tolerance to NT69L in mouse models for hypothermia and thermal analgesia.
2/2010	Chronic NT69L potently prevents drug-induced disruption of prepulse inhibition without causing tolerance.
1/2010	The novel neurotensin analog NT69L blocks phencyclidine (PCP)-induced increases in locomotor activity and PCP-induced increases in monoamine and amino acids levels in the medial prefrontal cortex.
9/2008	Effect of a novel neurotensin analog, NT69L, on nicotine-induced alterations in monoamine levels in rat brain.
10/2003	Current topics: brain penetrating neurotensin analog.
10/2003	Selective tolerance to the hypothermic and anticataleptic effects of a neurotensin analog that crosses the blood-brain barrier.
1/2003	Blockade of nicotine-induced locomotor sensitization by a novel neurotensin analog in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mona Boules Research Topics

Disease

9	Schizophrenia (Dementia Praecox) 01/2013 - 10/2003
5	Parkinson Disease (Parkinson's Disease) 01/2013 - 01/2002
5	Tobacco Use Disorder (Nicotine Dependence) 09/2008 - 01/2003
3	Pain (Aches) 01/2013 - 01/2010
3	Hypothermia 10/2011 - 10/2003
1	Cocaine-Related Disorders (Cocaine Addiction) 03/2014
1	Feeding and Eating Disorders (Eating Disorder) 01/2013
1	Neoplasms (Cancer) 01/2013
1	Substance-Related Disorders (Drug Abuse) 01/2013
1	Inflammation (Inflammations) 01/2013
1	Visceral Pain 06/2012
1	Brain Diseases (Brain Disorder) 01/2010
1	Hypotension (Low Blood Pressure) 01/2010
1	Weight Gain 01/2007
1	Central Nervous System Diseases (CNS Diseases) 04/2005
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2004
1	Alzheimer Disease (Alzheimer's Disease) 01/2004
1	Catalepsy 10/2003

Drug/Important Bio-Agent (IBA)

12	NeurotensinIBA 03/2014 - 01/2002
8	neurotensin 69LIBA 06/2012 - 01/2003
4	Therapeutic UsesIBA 03/2014 - 04/2005
4	Neurotransmitter Agents (Neurotransmitter)IBA 01/2013 - 01/2002
3	Neurotensin Receptors (Neurotensin Receptor)IBA 11/2010 - 09/2008
3	Antipsychotic Agents (Antipsychotics)IBA 01/2010 - 01/2007
2	Nicotine FDA Link 03/2014 - 01/2003
2	Cocaine (Cocaine HCl)IBA 03/2014 - 10/2003
2	Analgesics (Analgesic Drugs)IBA 06/2012 - 09/2011
2	Proteins (Proteins, Gene)FDA Link 11/2010 - 01/2004
2	Amphetamine (Amfetamine)FDA LinkGeneric 11/2010 - 06/2010
2	Apomorphine FDA Link 01/2010 - 10/2003
2	Dextroamphetamine (Dexedrine)FDA LinkGeneric 01/2010 - 10/2003
2	Peptide Hydrolases (Proteases)FDA Link 10/2006 - 04/2005
1	Pharmaceutical PreparationsIBA 03/2014
1	levocabastine (Bilina)FDA Link 06/2012
1	Morphine (MS Contin)FDA LinkGeneric 09/2011
1	Formaldehyde (Formol)FDA Link 09/2011
1	Phencyclidine (Angel Dust)IBA 11/2010
1	Amino Acids FDA Link 06/2010
1	Glutamic Acid (Glutamate)FDA Link 01/2010
1	Dopamine (Intropin)FDA LinkGeneric 01/2010
1	Acetic Acid (Vinegar)FDA LinkGeneric 01/2010
1	NeuropeptidesIBA 01/2007
1	Peptides (Polypeptides)IBA 04/2005
1	Amyloid (Amyloid Fibrils)IBA 01/2004
1	amyloid beta-protein (1-42)IBA 01/2004
1	Amyloid beta-PeptidesIBA 01/2004
1	Blood Glucose (Blood Sugar)IBA 10/2003
1	Haloperidol (Haldol)FDA LinkGeneric 10/2003
1	Hydrocortisone (Cortisol)FDA LinkGeneric 10/2003

Therapy/Procedure

2	Analgesia 06/2012 - 10/2011
1	Therapeutics 09/2011
1	Drug Therapy (Chemotherapy) 01/2010